IGF1R and cancer: We have provided evidences that such an engineered molecule, PTB-U-box, can effectively degrades IGF-1R/IR, inhibits cell proliferation and invasion, increases chemo-sensitivity and reduces glucose metabolism when ectopically expressed in cancer cells.